Nihanthy Sreenath
@nihanthy
Followers
94
Following
175
Media
2
Statuses
64
🎗️ Medical Oncologist | 🎓 Cancer Educator | 🧬 AYA, Breast, Gyn, GI Cancers | 💉 BMT & CAR-T | Passionate about evidence, equity & empathy in oncology
Kolkata
Joined January 2010
Grateful to OncoDaily for the feature and the continued focus on impactful oncology conversations. @SuyogCancer @ErikaHamilton9 @elmayermd @drsarahsam @jhaveri_komal
linkedin.com
Grateful to OncoDaily for the feature and the continued focus on impactful oncology conversations. Amol Akhade Sarah Sammons MD Komal Jhaveri, MD FACP, FASCO Erika Hamilton, MD, FASCO Dr Senthil...
0
1
6
Thank you Amol Sir @SuyogCancer. It was truly an enriching and insightful discussion. Grateful for the learning and perspectives shared.
We have a wonderful webinar on SABCS 2025 update. Close to 190 oncologist attended the same . I thank all the faculty @ErikaHamilton9 @elmayermd @drsarahsam @jhaveri_komal @nihanthy and Dr Senthil for taking time out from their busy schedule Great learnings 🙂🙏
0
1
1
We have a wonderful webinar on SABCS 2025 update. Close to 190 oncologist attended the same . I thank all the faculty @ErikaHamilton9 @elmayermd @drsarahsam @jhaveri_komal @nihanthy and Dr Senthil for taking time out from their busy schedule Great learnings 🙂🙏
1
3
32
It is tomorrow 16 th December 7.30 AM CST 8.30 AM EST 7.00 PM IST Webinar on SABCS 2025 updates Do Join Us @ErikaHamilton9 @elmayermd @drsarahsam @jhaveri_komal @nihanthy Link to join 🙂👇
us02web.zoom.us
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom...
Thats the registration link 🙂👇 Do Register. It is on 16 th December 7 pm IST /7.30 am CST . https://t.co/hLn6v7dfXH
1
5
8
Thats the registration link 🙂👇 Do Register. It is on 16 th December 7 pm IST /7.30 am CST . https://t.co/hLn6v7dfXH
us02web.zoom.us
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom...
1
2
7
SABCS 25 is going on in full force . Those of you who could not attend it in person , we have you covered. Do Join us for this exciting webinar on post SABCS updates on 16 th December 2025 , 6.30 PM IST / 7.30 am CST @drsarahsam @ErikaHamilton9 @elmayermd @jhaveri_komal
0
9
28
2. Grateful to @ctosociety for the travel award that made it possible. Deep thanks to @samdoc_mamc for the mentorship and support to present our work. @nihanthy @MedGenomeLabs @BahlCharu @OncoDaily @OncoAlert @CTOSarcoma @AIIMS_NEWDELHI @ASCO @JCOGlobalOnc @Oncology_News
0
2
2
Insightful Discussion on PACIFIC vs KEYNOTE-799 at AROICON 2025 - @nihanthy
https://t.co/aLL5mIN2qN
#Cancer #Medicine #Health #Oncology #OncoDaily #LungCancer #PACIFIC #KEYNOTE_799 #AROICON #MedX #MedNews #MedEd
0
1
4
Thrilled to share our new article, “Enhancing Oncological Care for India’s Aging Population.” Grateful to my co-authors. Hoping this contributes meaningfully to improving cancer care for older adults in India. #GeriatricOncology #CancerCare
onlinelibrary.wiley.com
Aging-associated physiological and molecular alterations pose significant challenges in cancer management among India's elderly. Limited geriatric oncology expertise, financial constraints, and...
0
0
0
Caveats and Nuances of Checkmate 9DW in Advanced HCC - @tuttsakhil
@nihanthy
https://t.co/PwzlNN8sQ1
#Cancer #Medicine #Health #Oncology #OncoDaily #HCC #LiverCancer #Checkmate9DW #MedX #MedNews #MedEd
0
3
5
CheckMate 9DW shows remarkable OS in advanced HCC, but real-world adoption is more complex. Our Lancet piece highlights why context and feasibility still matter. Grateful to contribute to this important conversation @tuttsakhil
Happy to share our comments on the Checkmate 9dw trial, published in this week's lancet @nihanthy @TheLancet @oncodaily
0
0
1
Happy to share our comments on the Checkmate 9dw trial, published in this week's lancet @nihanthy @TheLancet @oncodaily
thelancet.com
Thomas Yau and colleagues’ CheckMate 9DW trial has yielded unprecedented results, with nivolumab plus ipilimumab reaching an overall response rate of 36%, a median progression-free survival of 9·1...
1
5
17
10 Oncology Experts Join OncoDaily Medical Journal’s Editorial Team https://t.co/TpuGRpNMHe
@Chris_PouliosMD @drshabanjuma @nihanthy @JackShireman
#Cancer #Medicine #Health #Oncology #OncoDaily #ODMJ #MedX #MedNews #MedEd
0
4
6
Thanks @Vineeth06760017 ! Prospective study of high dose ifosfsmide in advanced synovial sarcoma from @aiims_newdelhi #sarcoma @RashiKapoor17 @SachinSarcoma @CureSynovial @Thalcin @sorunshishak @tuttsakhil @nihanthy
Presented our study in CTOS 2025 as poster! Highlights 1/ 🔥 Phase II High-Dose Ifosfamide (HD-IFO) in Metastatic/Unresectable Synovial Sarcoma Prospective single-arm study from a tertiary sarcoma center. N = 25 translocation-positive patients.
2
6
12
KEYNOTE-564’s Impact on Adjuvant Immunotherapy in RCC - Nihanthy Sreenath @nihanthy @tuttsakhil
https://t.co/tj35nOHcfl
#Cancer #Medicine #Health #Oncology #OncoDaily #RCC #Immunotherapy #KEYNOTE564 #MedX #MedNews #MedEd
0
5
10
Excited to see our own, dynamic clinician and researcher, Dr Neeraj Agarwal running for ASCO nominating seat. Throwing our full weight behind him @batraatulonc @DrNikitaMehra @DrJasminPorwall @DharamKaushik5 @drshubhamsahni @RanjitKSMD @dr_rajapramanik @nihanthy @garg_h
Voting for the ASCO election is now open! I am honored to be running as one of the candidates for the @ASCO Nominating Committee seat. Visit https://t.co/4riSVk7AQy to learn more about the candidates and place your vote! Thank you!!
0
6
9
Pleased to share our short commentary on the current adjuvant therapy landscape in RCC @nihanthy
https://t.co/8ul4Ty800C
1
3
10
Grateful to be part of #ESMO2025-Berlin, with inspiring discussions at the Young Oncologists Forum & Women for Oncology (W4O) Humbled to present my poster; grateful for the guidance & support of mentors💫 @ISMPOofficial @oncodaily
#Oncology #W4O #YoungOncologists #Gratitude
0
0
5